Amyloid β induces interneuron-specific changes in the hippocampus of APPNL-F mice

Fiji: an open-source platform for biological-image analysis

Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · see citing works

The amyloid hypothesis of Alzheimer's disease at 25 years

Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · see citing works

2016 Alzheimer's disease facts and figures

Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069 · see citing works

The global prevalence of dementia: a systematic review and metaanalysis.

Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Estimation of nuclear population from microtome sections

Abercrombie, M. (1946) · The Anatomical Record · doi:10.1002/ar.1090940210 · Cited by 4,363 · see citing works

Interneurons of the hippocampus

Freund, T. F., & Buzsáki, G. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:4 · Cited by 3,423 · see citing works

Theta oscillations in the hippocampus

Buzsáki, G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00586-x · Cited by 3,332 · see citing works

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160 · see citing works

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279 · see citing works

The Cellular Phase of Alzheimer’s Disease

De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · see citing works

Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria

Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925 · see citing works

Alzheimer Mechanisms and Therapeutic Strategies

Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · see citing works

Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study

Sierra, H., Cordova, M., Chen, C.-S. J., & Rajadhyaksha, M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.371 · Cited by 1,703 · see citing works

Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of alzheimer’s disease.

Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · see citing works

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,488 · see citing works

Single App knock-in mouse models of Alzheimer’s disease

Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., Iwata, N., & Saido, T. C. (2014) · Nature Neuroscience · doi:10.1038/nn.3697 · Cited by 1,447 · see citing works

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431 · see citing works

Amyloid, the presenilins and Alzheimer’s disease

Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370 · see citing works

Neuropathology of older persons without cognitive impairment from two community-based studies

Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · see citing works

Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates

Paxinos, G., & Franklin, K. B. J. (2012) · Cited by 1,267 · see citing works

Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques

Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988) · Annals of Neurology · doi:10.1002/ana.410230206 · Cited by 1,225 · see citing works

Fast-spiking, parvalbumin ⁺ GABAergic interneurons: From cellular design to microcircuit function

Hu, H., Gan, J., & Jonas, P. (2014) · Science · doi:10.1126/science.1255263 · Cited by 1,197 · see citing works

Frequent amyloid deposition without significant cognitive impairment among the elderly

Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., Ziolko, S. K., James, J. A., Snitz, B. E., Houck, P. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1509 · Cited by 1,059 · see citing works

Classification and basic pathology of Alzheimer disease

Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031 · see citing works

Review Article: Genetics of Alzheimer Disease

Bekris, L. M., Yu, C.-E., Bird, T. D., & Tsuang, D. W. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383571 · Cited by 1,029 · see citing works

Network abnormalities and interneuron dysfunction in Alzheimer disease

Palop, J. J., & Mucke, L. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.141 · Cited by 1,022 · see citing works

TrakEM2 Software for Neural Circuit Reconstruction

Cardona, A., Saalfeld, S., Schindelin, J., Arganda‐Carreras, I., Preibisch, S., Longair, M., Tomančák, P., Hartenstein, V., & Douglas, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038011 · Cited by 989 · see citing works

Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer’s disease

Reddy, P. H., & Beal, M. F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.002 · Cited by 975 · see citing works

A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease

Panza, F., Lozupone, M., Logroscino, G., & Imbimbo, B. P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0116-6 · Cited by 965 · see citing works

Differences between somatic and dendritic inhibition in the hippocampus

Miles, R., Tóth, K., Gulyás, A. I., Hájos, N., & Freund, T. F. (1996) · Neuron · doi:10.1016/s0896-6273(00)80101-4 · Cited by 942 · see citing works

Defined types of cortical interneurone structure space and spike timing in the hippocampus

Somogyi, P., & Klausberger, T. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.078915 · Cited by 927 · see citing works

Hippocampal GABAergic Inhibitory Interneurons

Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889 · see citing works

APP mouse models for Alzheimer’s disease preclinical studies.

Sasaguri, H., Nilsson, P., Hashimoto, S., Nagata, K., Saito, T., De Strooper, B., Hardy, J., Vassar, R., Winblad, B., & Saido, T. C. (2017) · The EMBO Journal · doi:10.15252/embj.201797397 · Cited by 793 · see citing works

Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & CEBALLOS, M. L. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 783 · see citing works

Cytoplasmic 5′-3′ exonuclease Xrn1p is also a genome-wide transcription factor in yeast

Medina, D. A., Jordán‐Pla, A., Millán-Zambrano, G., Chávez, S., Choder, M., & Pérez-Ortín, J. E. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00001 · Cited by 757 · see citing works

Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models

Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755 · cited 1× · see citing works

The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy

Sengupta, U., Nilson, A. N., & Kayed, R. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.035 · Cited by 740 · see citing works

Anxiety Cells in a Hippocampal-Hypothalamic Circuit

Jimenez, J., Su, K., Goldberg, A., Luna, V. M., Biane, J. S., Ordek, G., Zhou, P., Ong, S. K., Wright, M. A., Zweifel, L. S., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.016 · Cited by 606 · see citing works

Microglial response to amyloid plaques in APPsw transgenic mice.

Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592 · see citing works

Epileptic activity in Alzheimer’s disease: Causes and clinical relevance

Vossel, K. A., Tartaglia, M. C., Nygaard, H. B., Zeman, A. Z., & Miller, B. L. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30044-3 · Cited by 590 · see citing works

Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease

Barage, S. H., & Sonawane, K. D. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.06.008 · Cited by 579 · see citing works

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

Bateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573 · see citing works

Complementary Roles of Cholecystokinin- and Parvalbumin-Expressing GABAergic Neurons in Hippocampal Network Oscillations

Klausberger, T., Marton, L. F., O'Neill, J., Huck, J. H. J., Dalezios, Y., Fuentealba, P., Suen, W. Y., Papp, E., Kaneko, T., Watanabe, M., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3269-05.2005 · Cited by 469 · see citing works

An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?

Thomson, A. M., West, D. C., & Lodge, D. (1985) · Nature · doi:10.1038/313479a0 · Cited by 458 · see citing works

Age-related changes in behavior in C57BL/6J mice from young adulthood to middle age

Shoji, H., Takao, K., Hattori, S., & Miyakawa, T. (2016) · Molecular Brain · doi:10.1186/s13041-016-0191-9 · Cited by 452 · see citing works

Release probability of hippocampal glutamatergic terminals scales with the size of the active zone

Holderith, N., Lorincz, A., Katona, G., Rózsa, B., Kulik, A., Watanabe, M., & Nusser, Z. (2012) · Nature Neuroscience · doi:10.1038/nn.3137 · Cited by 405 · see citing works

Rodent models for Alzheimer disease

Götz, J., Bodea, L., & Goedert, M. (2018) · Nature reviews. Neuroscience · doi:10.1038/s41583-018-0054-8 · Cited by 397 · see citing works

Spike timing of dendrite-targeting bistratified cells during hippocampal network oscillations in vivo

Klausberger, T., Márton, L. F., Baude, A., Roberts, J. D. B., Magill, P. J., & Somogyi, P. (2004) · Nature Neuroscience · doi:10.1038/nn1159 · Cited by 393 · see citing works

Activation of microglia by aggregated β-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective

Butovsky, O., Talpalar, A. E., Ben‐Yaakov, K., & Schwartz, M. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.03.005 · Cited by 368 · see citing works

Mitochondrial calcium uptake

Williams, G. S. B., Boyman, L., Chikando, A. C., Khairallah, R. J., & Lederer, W. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300410110 · Cited by 362 · see citing works

The amyloid hypothesis on trial

Makin, S. (2018) · Nature · doi:10.1038/d41586-018-05719-4 · Cited by 360 · see citing works

Mitochondria: The calcium connection

Contreras, L., Drago, I., Zampese, E., & Pozzan, T. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.05.005 · Cited by 349 · see citing works

Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model

Kim, D.-G., Krenz, A., Toussaint, L. E., Maurer, K. J., Robinson, S.-A., Yan, A., Torres, L., & Bynoe, M. S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0467-5 · Cited by 330 · see citing works

Genes associated with Alzheimer's disease: an overview and current status

Giri, M., Lü, Y., & Zhang, M. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s105769 · Cited by 311 · see citing works

Cell Type-Specific Tuning of Hippocampal Interneuron Firing during Gamma Oscillations<i>In Vivo</i>

Tukker, J. J., Fuentealba, P., Hartwich, K., Somogyi, P., & Klausberger, T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1685-07.2007 · Cited by 304 · see citing works

Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease

Sadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., & Vassar, R. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1558-9 · Cited by 294 · see citing works

A new type of specific interneuron in the monkey hippocampus forming synapses exclusively with the axon initial segments of pyramidal cells

Somogyi, P., Nunzi, M. G., Gorio, A., & Smith, A. D. (1983) · Brain Research · doi:10.1016/0006-8993(83)91076-4 · Cited by 273 · see citing works

Inflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunization

Zotova, E., Bharambe, V., Cheaveau, M., Morgan, W., Holmes, C., Harris, S., Neal, J. W., Love, S., Nicoll, J. A. R., & Boche, D. (2013) · Brain · doi:10.1093/brain/awt210 · Cited by 272 · see citing works

Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease

Villegas-Llerena, C., Phillips, A., Garcia-Reitboeck, P., Hardy, J., & Pocock, J. M. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.10.004 · Cited by 270 · see citing works

Loss of functional GABA A receptors in the Alzheimer diseased brain

Limón, A., Reyes‐Ruiz, J. M., & Miledi, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204606109 · Cited by 264 · see citing works

Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients

Morrison, J. H., Rogers, J., Scherr, S., Benoit, R., & Bloom, F. E. (1985) · Nature · doi:10.1038/314090a0 · Cited by 264 · see citing works

Microglia and neuroprotection: implications for Alzheimer's disease

Streit, W. J. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.013 · Cited by 256 · see citing works

Neuroinflammation in Alzheimer's Disease: Mechanisms, Pathologic Consequences, and Potential for Therapeutic Manipulation

Hensley, K. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1414 · Cited by 250 · see citing works

Cognitive deficits in single App knock-in mouse models

Masuda, A., Kobayashi, Y., Kogo, N., Saito, T., Saido, T. C., & Itohara, S. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.07.001 · Cited by 248 · see citing works

Perineuronal nets potentially protect against oxidative stress

Morawski, M., Brückner, M. K., Riederer, P., Brückner, G., & Arendt, T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.04.017 · Cited by 246 · see citing works

Seizures and Epilepsy in Alzheimer's Disease

Friedman, D., Honig, L. S., & Scarmeas, N. (2012) · CNS Neuroscience &amp; Therapeutics · doi:10.1111/j.1755-5949.2011.00251.x · Cited by 229 · see citing works

Enhancing Serial Block-Face Scanning Electron Microscopy to Enable High Resolution 3-D Nanohistology of Cells and Tissues

Deerinck, T., Bushong, E., Lev‐Ram, V., Shu, X., Tsien, R. Y., & Ellisman, M. H. (2010) · Microscopy and Microanalysis · doi:10.1017/s1431927610055170 · Cited by 227 · see citing works

Differential Relationships of Reactive Astrocytes and Microglia to Fibrillar Amyloid Deposits in Alzheimer Disease

Serrano-Pozo, A., Muzikansky, A., Gómez-Isla, T., Growdon, J. H., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2013) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/nen.0b013e3182933788 · Cited by 226 · see citing works

Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus

Sanchez-Varo, R., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Baglietto-Vargas, D., Moreno-Gonzalez, I., De Castro, V., Jimenez, S., Ruano, D., Vizuete, M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0896-x · Cited by 222 · see citing works

Bone mineral density, adiposity, and cognitive functions

Sohrabi, H. R., Bates, K. A., Weinborn, M., Bucks, R. S., Rainey‐Smith, S. R., Rodrigues, M. A., Bird, S., Brown, B. M., Beilby, J. P., Howard, M., et al. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00016 · Cited by 222 · see citing works

Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease

Gomez‐Arboledas, A., Davila, J. C., Sanchez‐Mejias, E., Navarro, V., Nuñez‐Diaz, C., Sanchez‐Varo, R., Sanchez‐Mico, M. V., Trujillo‐Estrada, L., Fernandez‐Valenzuela, J. J., Vizuete, M., et al. (2018) · Glia · doi:10.1002/glia.23270 · Cited by 220 · see citing works

Microglial immunophenotype in dementia with Alzheimer’s pathology

CFAS, M., Minett, T., Classey, J., Matthews, F. E., Fahrenhold, M., Taga, M., Brayne, C., Ince, P. G., Nicoll, J. A. R., & Boche, D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0601-z · Cited by 219 · see citing works

Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1×APP transgenic model of Alzheimer's disease

Ramos, B., Baglietto‐Vargas, D., del Río, J. C., Moreno‐González, I., Santa‐María, C., Jiménez, S., Caballero, C., Lopez-Tellez, J. F., Khan, Z. U., Ruano, D., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.022 · Cited by 213 · see citing works

Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?

Mullane, K., & Williams, M. J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.014 · Cited by 212 · see citing works

Postsynaptic targets of somatostatin-immunoreactive interneurons in the rat hippocampus

Katona, I., Acsády, L., & Freund, T. F. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00302-9 · Cited by 206 · see citing works

Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease

Geula, C., Nagykery, N. G., Nicholas, A., & Wu, C. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a1df3 · Cited by 203 · see citing works

GABAB receptors: synaptic functions and mechanisms of diversity

Ulrich, D., & Bettler, B. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.04.001 · Cited by 201 · see citing works

Histochemical localization of cytochrome oxidase in the hippocampus: Correlation with specific neuronal types and afferent pathways

Kageyama, G. H., & Wong‐Riley, M. T. T. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90199-3 · Cited by 200 · see citing works

Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms

Sheng, J. G., Mrak, R. E., & Griffin, W. S. T. (1997) · Acta Neuropathologica · doi:10.1007/s004010050664 · Cited by 191 · see citing works

Neuronal Hypertrophy in Asymptomatic Alzheimer Disease

Iacono, D., O'Brien, R., Resnick, S. M., Zonderman, A. B., Pletnikova, O., Rudow, G., An, Y., West, M. J., Crain, B., & Troncoso, J. C. (2008) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/nen.0b013e3181772794 · Cited by 188 · see citing works

Cerebral Amyloid Induces Aberrant Axonal Sprouting and Ectopic Terminal Formation in Amyloid Precursor Protein Transgenic Mice

Phinney, A. L., Deller, T., Stalder, M., Calhoun, M. E., Frotscher, M., Sommer, B., Staufenbiel, M., & Jucker, M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08552.1999 · Cited by 187 · see citing works

Co-transmission of acetylcholine and GABA regulates hippocampal states

Takács, V. T., Cserép, C., Schlingloff, D., Pósfai, B., Szőnyi, A., Sos, K. E., Környei, Z., Dénes, Á., Gulyás, A. I., Freund, T. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05136-1 · Cited by 169 · see citing works

Amyloid‐ß‐directed immunotherapy for Alzheimer's disease

Lannfelt, L., Relkin, N. R., & Siemers, E. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12168 · Cited by 157 · see citing works

Populations of hippocampal inhibitory neurons express different levels of cytochrome <i>c</i>

Gulyás, A. I., Buzsáki, G., Freund, T. F., & Hirase, H. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04814.x · Cited by 142 · see citing works

Perineuronal nets in brain physiology and disease

Testa, D., Prochiantz, A., & Nardo, A. A. D. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.09.011 · Cited by 141 · see citing works

A unifying hypothesis for Alzheimer's disease: from plaques to neurodegeneration

Edwards, F. A. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.03.003 · Cited by 140 · see citing works

Interneuron loss reduces dendritic inhibition and GABA release in hippocampus of aged rats

Stanley, E. M., Fadel, J. R., & Mott, D. D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.014 · Cited by 130 · see citing works

Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer’s diseased brain

Brady, D. R., & Mufson, E. J. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00068-7 · Cited by 125 · see citing works

Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease

Takahashi, H., Brasnjevic, I., Rutten, B. P. F., Van Der Kolk, N., Perl, D. P., Bouras, C., Steinbusch, H. W. M., Schmitz, C., Hof, P. R., & Dickstein, D. L. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0242-4 · Cited by 124 · see citing works

How the 'slow' Ca2+ buffer parvalbumin affects transmitter release in nanodomain-coupling regimes

Eggermann, E., & Jonas, P. (2012) · Nature Neuroscience · doi:10.1038/nn.3002 · Cited by 119 · see citing works

Immunocytochemical characterization of hippocamposeptal projecting GABAergic nonprincipal neurons in the mouse brain: a retrograde labeling study

Jinno, S., & Kosaka, T. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02804-4 · Cited by 117 · see citing works

Extracellular matrix proteomics in schizophrenia and Alzheimer’s disease

Sethi, M. K., & Zaia, J. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9900-6 · Cited by 109 · see citing works

Familial Alzheimer’s Disease Mutations in Presenilin Generate Amyloidogenic Aβ Peptide Seeds

Veugelen, S., Saito, T., Saido, T. C., Chávez‐Gutiérrez, L., & Strooper, B. D. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.010 · Cited by 107 · see citing works

New Mouse Model of Alzheimer’s

Nilsson, P., Saito, T., & Saido, T. C. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500105p · Cited by 107 · see citing works

Plaque‐dependent morphological and electrophysiological heterogeneity of microglia in an A lzheimer's disease mouse model

Plescher, M., Seifert, G., Hansen, J. N., Bedner, P., Steinhäuser, C., & Halle, A. (2018) · Glia · doi:10.1002/glia.23318 · Cited by 101 · see citing works

Low rates of antibiotic resistance and infectious mortality in a cohort of high-risk hematology patients: A single center, retrospective analysis of blood stream infection

Conn, J. R., Catchpoole, E. M., Runnegar, N. J., Mapp, S., & Markey, K. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178059 · Cited by 99 · see citing works

Perineuronal nets ensheath fast spiking, parvalbumin‐immunoreactive neurons in the medial septum/diagonal band complex

Morris, N. P., & Henderson, Z. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00970.x · Cited by 98 · see citing works

Alzheimer's disease: The amyloid hypothesis on trial

Harrison, J. R., & Owen, M. J. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.167569 · Cited by 96 · see citing works

Vision function abnormalities in Alzheimer disease

Tzekov, R., & Mullan, M. (2014) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2013.10.002 · Cited by 94 · see citing works

Early disruption of parvalbumin expression and perineuronal nets in the hippocampus of the Tg2576 mouse model of Alzheimer's disease can be rescued by enriched environment

Cattaud, V., Bezzina, C., Rey, C. C., Lejards, C., Dahan, L., & Verret, L. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.024 · Cited by 88 · see citing works

Identification and distribution of axonal dystrophic neurites in Alzheimer's disease

Su, J. H., Cummings, B. J., & Cotman, C. W. (1993) · Brain Research · doi:10.1016/0006-8993(93)91063-x · Cited by 84 · see citing works

Rasd1, a small G protein with a big role in the hypothalamic response to neuronal activation

Greenwood, M. P., Greenwood, M., Mecawi, A. S., Antunes‐Rodrigues, J., Paton, J. F. R., & Murphy, D. (2016) · Molecular Brain · doi:10.1186/s13041-015-0182-2 · Cited by 83 · see citing works

First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression

Cummings, D. M., Liu, W., Portelius, E., Bayram, S., Yasvoina, M. V., Ho, H., Smits, H., Ali, S. S., Steinberg, R., Pegasiou, C.-M., et al. (2015) · Brain · doi:10.1093/brain/awv127 · Cited by 81 · see citing works

Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer’s disease

Albuquerque, M. S., Mahar, I., Davoli, M. A., Chabot, J.-G., Mechawar, N., Quirion, R., & Krantic, S. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00030 · Cited by 71 · see citing works

Quantitative ultrastructural analysis of basket and axo-axonic cell terminals in the mouse hippocampus

Takács, V. T., Szőnyi, A., Freund, T. F., Nyíri, G., & Gulyás, A. I. (2014) · Brain Structure and Function · doi:10.1007/s00429-013-0692-6 · Cited by 69 · see citing works

Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer’s disease pathogenesis

D’Andrea, M., & Nagele, R. (2010) · Biotechnic & Histochemistry · doi:10.3109/10520290903389445 · Cited by 66 · see citing works

Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease

Sakakibara, Y., Sekiya, M., Saito, T., Saido, T. C., & Iijima, K. M. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0496-6 · Cited by 65 · cited 1× · see citing works

Substance P and somatostatin coexist within neuritic plaques: Implications for the pathogenesis of Alzheimer's disease

Armstrong, D. M., Benzing, W. C., Evans, J. A., Terry, R. D., Shields, D., & Hansen, L. A. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90431-4 · Cited by 63 · see citing works

High plasticity of axonal pathology in Alzheimer’s disease mouse models

Blázquez‐Llorca, L., Valero-Freitag, S., Rodrigues, E. F., Merchán-Pérez, Á., Rodríguez, J., Dorostkar, M. M., DeFelipe, J., & Herms, J. W. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0415-y · Cited by 62 · see citing works

Calcium in the initiation, progression and as an effector of Alzheimer’s disease pathology

Green, K. N. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00861.x · Cited by 56 · see citing works

Properties of horizontal axo‐axonic cells in stratum oriens of the hippocampal CA1 area of rats in vitro

Ganter, P., Szűcs, P., Paulsen, O., & Somogyi, P. (2004) · Hippocampus · doi:10.1002/hipo.10170 · Cited by 46 · see citing works

Subfield and layer-specific depletion in calbindin-D28K, calretinin and parvalbumin immunoreactivity in the dentate gyrus of amyloid precursor protein/presenilin 1 transgenic mice

Popović, M., Caballero-Bleda, M., Kadish, I., & Van Groen, T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.023 · Cited by 38 · see citing works

Vulnerability of calbindin, calretinin and parvalbumin in a transgenic/knock-in APPswe/PS1dE9 mouse model of Alzheimer disease together with disruption of hippocampal neurogenesis

Verdaguer, E., Brox, S., Petrov, D., Olloquequi, J., Romero, R., de Lemos, M. L., Camins, A., & Auladell, C. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.06.013 · Cited by 38 · see citing works

Major Clinical Trials Failed the Amyloid Hypothesis of Alzheimer's Disease

Huang, Y., Shen, J. X., & Zhao, H. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15830 · Cited by 32 · see citing works

Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice

Steffen, J., Krohn, M., Schwitlick, C., Brüning, T., Paarmann, K., Pietrzik, C. U., Biverstål, H., Jansone, B., Langer, O., & Pahnke, J. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0448-2 · Cited by 31 · see citing works

Threat Perception in Mild Cognitive Impairment and Early Dementia

Henry, J. D., Thompson, C. L., Ruffman, T., Leslie, F., Withall, A., Sachdev, P. S., & Brodaty, H. (2009) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbp064 · Cited by 31 · see citing works

Retinal Manifestations of Alzheimer’s Disease

Dehabadi, M. H., Davis, B. M., Wong, T. K. Y., & Cordeiro, M. F. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.19 · Cited by 28 · see citing works

The Disease-modifying Drug Candidate, SAK3 Improves Cognitive Impairment and Inhibits Amyloid beta Deposition in App Knock-in Mice

Izumi, H., Shinoda, Y., Saito, T., Saido, T. C., Sato, K., Yabuki, Y., Matsumoto, Y., Kanemitsu, Y., Tomioka, Y., Abolhassani, N., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.031 · Cited by 28 · see citing works

Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APPSwe/PSEN1M146V transgenic mice

Medawar, E., Benway, T. A., Liu, W., Hanan, T. A., Haslehurst, P., James, O. T., Yap, K., Muessig, L., Moroni, F., Nahaboo Solim, M. A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.006 · Cited by 26 · see citing works

Effect of lesion proximity on the regenerative response of long descending propriospinal neurons after spinal transection injury

Swieck, K., Conta, A. C., Middleton, F. A., Siebert, J. R., Osterhout, D. J., & Stelzner, D. J. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0491-y · Cited by 22 · see citing works

A website entitled “The fine structure of the aging brain”

Peters, A., & Folger, C. (2012) · The Journal of Comparative Neurology · doi:10.1002/cne.23280 · Cited by 22 · see citing works

THE GENETICS OF ALZHEIMER DISEASE

Pericak‐Vance, M. A. (2003) · doi:10.1142/9789812705150_0070 · Cited by 14 · see citing works

Characterization of SiGe Films for Use as a National Institute of Standards and Technology Microanalysis Reference Material (RM 8905)

Marinenko, R. B., Turner, S., Simons, D. S., Rabb, S. A., Zeisler, R. L., Yu, L. L., Newbury, D. E., Paul, R. L., Ritchie, N. W. M., Leigh, S. D., et al. (2009) · Microscopy and Microanalysis · doi:10.1017/s1431927609991231 · Cited by 9 · see citing works

Axonal Tract Tracing For Delineating Interacting Brain Regions: Implications For Alzheimer‘s Disease-Associated Memory

van Groen, T., Miettinen, P., & Kadish, I. (2013) · Future Neurology · doi:10.2217/fnl.13.67 · Cited by 5 · see citing works

Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums

Kamondi, A., Grigg-Damberger, M. M., Löscher, W., Tanila, H., & Horvath, A. A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00932-4 · Cited by 102 · see citing works

Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia

Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N. S. M., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00457-0 · Cited by 79 · see citing works

The Role of Extracellular Matrix in Human Neurodegenerative Diseases

Pintér, P., & Alpár, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911085 · Cited by 66 · see citing works

An Expanded Narrative Review of Neurotransmitters on Alzheimer’s Disease: The Role of Therapeutic Interventions on Neurotransmission

Akyuz, E., Arulsamy, A., Aslan, F. S., Sarisözen, B., Guney, B., Hekimoglu, A., Yilmaz, B. N., Retinasamy, T., & Shaikh, M. F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04333-y · Cited by 69 · see citing works

The “Loss” of Perineuronal Nets in Alzheimer's Disease: Missing or Hiding in Plain Sight?

Scarlett, J. M., Hu, S. J., & Alonge, K. M. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.896400 · Cited by 61 · see citing works

Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer’s pathology

Kumar, P., Goettemoeller, A. M., Espinosa‐García, C., Tobin, B. R., Tfaily, A., Nelson, R. S., Natu, A., Dammer, E. B., Santiago, J. V., Malepati, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47028-7 · Cited by 48 · see citing works

Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease

Morrone, C. D., Lai, A. Y., Bishay, J., Hill, M. E., & McLaurin, J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00300-6 · Cited by 43 · see citing works

Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease

Gutierrez, B. A., & Limón, A. (2022) · Biomedicines · doi:10.3390/biomedicines10071743 · Cited by 31 · see citing works

Local and long-range GABAergic circuits in hippocampal area CA1 and their link to Alzheimer’s disease

Hernández‐Frausto, M., Bilash, O. M., Masurkar, A. V., & Basu, J. (2023) · Frontiers in Neural Circuits · doi:10.3389/fncir.2023.1223891 · Cited by 33 · see citing works

Perineuronal net deglycosylation associates with tauopathy‐induced gliosis and neurodegeneration

Logsdon, A. F., Foresi, B., Hu, S. J., Quah, E., Meuret, C. J., Le, J. P., Hendrickson, A. S., Redford, I. K., Kumar, A., Phan, B. A., et al. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16067 · Cited by 16 · see citing works

Alzheimer's disease/dementia-associated brain pathology in aging DPP6-KO mice

Lin, L., Petralia, R. S., Holtzclaw, L. A., Wang, Y., Abebe, D. T., & Hoffman, D. A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105887 · Cited by 16 · see citing works

The Bidirectional Relationship Between Epilepsy and Alzheimer’s Disease

Stewart, D., & Johnson, E. L. (2025) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-025-01404-y · Cited by 16 · see citing works

Somatostatin slows Aβ plaque deposition in aged APPNL-F/NL-F mice by blocking Aβ aggregation

Williams, D., Yan, B. Q., Wang, H., Negm, L., Sackmann, C., Verkuyl, C. E., Rezai-Stevens, V., Eid, S., Vediya, N., Sato, C., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29559-z · Cited by 11 · see citing works

Linking Social Cognition, Parvalbumin Interneurons, and Oxytocin in Alzheimer’s Disease: An Update

Černotová, D., Hrůzová, K., Levčík, D., Svoboda, J., & Stuchlı́k, A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230333 · Cited by 12 · see citing works

Prenatal stress aggravates age-dependent cognitive decline, insulin signaling dysfunction, and the pro-inflammatory response in the APPNL-F/NL-F mouse model of Alzheimer's disease

Trojan, E., Curzytek, K., Cieślik, P., Wierońska, J. M., Gräff, J., Lasoń, W., Saito, T., Saido, T. C., & Basta‐Kaim, A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106219 · Cited by 8 · see citing works

Altered APP trafficking drives amyloidogenic processing in primary neurons from the AppNL-F knock-in mouse model of Alzheimer's disease

Yu, Y., Zhou, R. Z., Nilsson, P., Winblad, B. G., Tjernberg, L. O., & Schedin‐Weiss, S. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107129 · Cited by 5 · see citing works

Amyloid Pathology Impairs Experience-Dependent Inhibitory Synaptic Plasticity

Niraula, S., Yan, S. S., & Subramanian, J. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0702-23.2023 · Cited by 7 · see citing works

Specific and Plastic: Chandelier Cell-to-Axon Initial Segment Connections in Shaping Functional Cortical Network

Qi, Y., Zhao, R., Tian, J., Lu, J., He, M., & Tai, Y. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01266-3 · Cited by 6 · see citing works

Quantification and correlation of amyloid-β plaque load, glial activation, GABAergic interneuron numbers, and cognitive decline in the young TgF344-AD rat model of Alzheimer’s disease

Futácsi, A., Rusznák, K., Szarka, G., Völgyi, B., Wiborg, O., & Czéh, B. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1542229 · Cited by 4 · see citing works

Native-state proteomics of Parvalbumin interneurons identifies novel molecular signatures and metabolic vulnerabilities to early Alzheimer’s disease pathologyPreprint

Kumar, P., Goettemoeller, A. M., Espinosa‐García, C., Tobin, B. R., Tfaily, A., Nelson, R. S., Natu, A., Dammer, E. B., Santiago, J. V., Malepati, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.17.541038 · Cited by 4 · see citing works

Early social deficits in TgF344-AD rats are accompanied by sex-specific parvalbumin-positive interneuron reduction and altered brain oscillations in the hippocampal CA2

Černotová, D., Hrůzová, K., Touš, J., Janča, R., Stuchlı́k, A., Levčík, D., & Svoboda, J. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106875 · Cited by 3 · see citing works

Homeostatic plasticity of axonal excitable sites in Alzheimer's disease

Quintela‐López, T., & Lezmy, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1277251 · Cited by 3 · see citing works

Regional alterations of parvalbumin interneurons in human App knock-in mouse model of Alzheimer’s disease pathology

Gonzalez, M. M., Magondu, B., Rowan, M. J., & Forest, C. R. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.05.005 · Cited by 1 · see citing works

Somatostatin slows Aβ plaque deposition in aged APP NL-F/NL-F mice by blocking Aβ aggregation in a neprilysin-independent mannerPreprint

Williams, D., Yan, B. Q., Wang, H., Negm, L., Sackmann, C., Verkuyl, C. E., Rezai-Stevens, V., Eid, S., Sato, C., Watts, J. C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.26.509540 · Cited by 1 · see citing works

An increased excitation and inhibition onto CA1 pyramidal cells sets the path to Alzheimer’s diseasePreprint

Wehrle, P. H., Rathwell, T. J., Petroccione, M. A., Caiazza, E. D., Manning, A. K., dos Reis, L. F., Todd, G. C., Affinnih, N., Ahmad, S., Mehdi, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.27.656417 · Cited by 1 · see citing works

Applications of App and MAPT knock-in mice to understanding disease mechanisms

Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00006-1

Additional file 3 of Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia

Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992873

Additional file 5 of Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia

Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992879

Additional file 2 of Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia

Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992870

Additional file 6 of Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia

Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992882

Additional file 4 of Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia

Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992876

Additional file 1 of Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia

Benítez, D. P., Jiang, S., Wood, J. I., Wang, R., Hall, C. M., Peerboom, C., Wong, N., Stringer, K. M., Vitanova, K. S., Smith, V. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14992867

Structural and ultrastructural organization of the parietal cortex and dorsal hippocampus in transgenic 5xFAD mice administered sodium valproate, a histone deacetylase inhibitor

Tumanova, N. L., Vasilev, D. S., Dubrovskaya, N. M., & Nalivaeva, N. N. (2025) · Veterinary Science Development · doi:10.4081/vsd.2025.10639

Digging Deep into Alzheimer Disease: How Electron Microscopy Helps Elucidating Its Pathogenesis

Dallere, S., Migheli, A., & Vercelli, A. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01676-z

Selective weakening of population-coupled synaptic activity in vivo in a mouse model of amyloid-beta pathology

Melgosa-Ecenarro, L., Radulescu, C. I., Doostdar, N., Airey, J., Chaloner, F. A., Zabouri, N., Pedretti, G., Osso, F., Perez, L. G., Pilch, K. S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69866-3 · Cited by 2 · see citing works

Implication de nouvelles cibles microgliales, Cst7 et Clec7a/Dectin-1, dans le développement et la progression de la maladie d'Alzheimer

Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f

Parvalbumin interneurons in Alzheimer's disease: Physiological insights and pathophysiological mechanisms

Wu, M., Zeng, X., Cai, Y., Chen, H., Li, Q., & Yang, H. (2026) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70105

Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer’s disease

Hijazi, S., Heistek, T. S., Scheltens, P., Neumann, U., Shimshek, D. R., Mansvelder, H. D., Smit, A. B., & van Kesteren, R. E. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0483-4 · Cited by 216 · see citing works

Loss of Hippocampal Calretinin and Parvalbumin Interneurons in the 5XFAD Mouse Model of Alzheimer’s Disease

Giesers, N. K., & Wirths, O. (2020) · ASN Neuro · doi:10.1177/1759091420925356 · Cited by 47 · see citing works

Interneuron hyperexcitability as both causal factor and risk factor in Alzheimer’s disease

Hijazi, S., Heistek, T. S., Scheltens, P., Mansvelder, H. D., Smit, A. B., & van Kesteren, R. E. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.040877 · Cited by 3 · see citing works

Age‐Dependent Changes in Perineuronal Nets and Associated Parvalbumin Interneurons in the 5xFAD Amyloidosis Mouse Model

Nelson, R. S., Rangaraju, S., Rayaprolu, S., Kumar, P., Espinosa‐García, C., & Xiao, H. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.083101

Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease

Takahashi, H., Brasnjevic, I., Rutten, B. P. F., Van Der Kolk, N., Perl, D. P., Bouras, C., Steinbusch, H. W. M., Schmitz, C., Hof, P. R., & Dickstein, D. L. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0242-4 · Cited by 124 · see citing works